CUSABIO has developed 7 N Antibodies (3 recombinant antibodies) for SARS-CoV-2 research. Among of them, there are 3 recombinant antibodies, which are validated in ELISA, and two of them is validated in WB and GICA. Besides, CUSABIO also provides four SARS-CoV-2 Spike RBD Antibody Pair 1 for SARS-CoV-2 research.More>>
CUSABIO supplies 8 S antibodies for SARS-CoV-2 research, including 2 S polyclonal antibodies, 3 S monoclonal antibodies and 3 S recombinant antibodies. And one of the three S recombinant antibodies is nanobody validated in ELISA, GICA and Neutralising. Besides, CUSABIO also provides one SARS-CoV-2 Spike RBD Antibody Pair 1 for SARS-CoV-2 research.More>>
CUSABIO have developed several SARS-CoV-2 Spike S1 mutation recombinant proteins, including RBD (V367F), RBD (W436R), RBD (G476S), RBD (V483A), RBD (K417N), RBD (E484K) and S1 (D614G). All of these proteins are validated in SDS-PAGE and function ELISA.More>>
Join the 25,000 subscribers to get research hotpots, technical tips, latest information on events, sales and offers.
Sign up now!
We don't deal in spam.